RAINBOW: A global, phase 3, randomized, double-blind study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in the treatment of metastatic gastric adenocarcinoma following disease progression on first-line platinum- and fluoropyrimidine-containing combination therapy: Results of a multiple Cox regression analysis adjusting for prognostic factors.

被引：4

作者：

Wilke, Hansjochen

Van Cutsem, Eric

Oh, Sang Cheul

Bodoky, Gyorgy

Shimada, Yasuhiro

Hironaka, Shuichi

Sugimoto, Naotoshi

Lipatov, Oleg N.

Kim, Tae-You

Cunningham, David

Rougier, Philippe

Emig, Michael

Carlesi, Roberto

Chandrawansa, Kumari

Muro, Kei

Ohtsu, Atsushi

机构：

[1] Kliniken Essen Mitte Ctr Pallat Care, Essen, Germany

[2] Univ Hosp Gasthuisberg, Leuven, Belgium

[3] Korea Univ Guro Hosp, Seoul, South Korea

[4] Szent Laszlo Hosp, Budapest, Hungary

[5] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan

[6] Chiba Canc Ctr, Clin Trial Promot Dept, Chiba 2608717, Japan

[7] Osaka Med Ctr Canc & Cardiovasc Dis, Gastrointestinal Oncol, Osaka, Japan

[8] Bashkortostan Clin Oncol Ctr, Ufa, Russia

[9] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, Seoul 151, South Korea

[10] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Canc Res Inst, Seoul, South Korea

[11] Royal Marsden Hosp, Sutton, Surrey, England

[12] Univ Paris 05, Hop Europeen Georges Pompidou, F-75270 Paris 06, France

[13] Eli Lilly & Co, Heidelberg, Germany

[14] Eli Lilly Italia SpA, Sesto Fiorentino, FL, Italy

[15] Eli Lilly & Co, Bridgewater, NJ USA

[16] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi 464, Japan

[17] Natl Canc Ctr Hosp East, Div Gastrointestinal Oncol Digest, Endoscopy, Kashiwa, Chiba, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期

关键词：

D O I：

10.1200/jco.2014.32.15_suppl.4076

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

4076

引用

页数：1